Nanoemulsion adjuvantation strategy of tumor-associated antigen therapy rephrases mucosal and immunotherapeutic signatures following intranasal vaccination
Background Emulsion adjuvants are a potent tool for effective vaccination; however, the size matters on mucosal signatures and the mechanism of action following intranasal vaccination remains unclear. Here, we launch a mechanistic study to address how mucosal membrane interacts with nanoemulsion of...
Saved in:
| Main Authors: | Chung-Hsiung Huang, Chiung-Yi Huang, Hui-Min Ho, Ching-Hung Lee, Pang-Ti Lai, Suh-Chin Wu, Shih-Jen Liu, Ming-Hsi Huang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-10-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/8/2/e001022.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Vaccines of the Future: The Role of Inflammation and Adjuvanticity
by: Cheol-Heui Yun, et al.
Published: (2015-01-01) -
Innate Immune Memory: The Latest Frontier of Adjuvanticity
by: Elfi Töpfer, et al.
Published: (2015-01-01) -
Intranasal trivalent candidate vaccine induces strong mucosal and systemic immune responses against Neisseria gonorrhoeae
by: Qin Lu, et al.
Published: (2024-11-01) -
mRNA vaccine designs for optimal adjuvanticity and delivery
by: Yuki Mochida, et al.
Published: (2024-12-01) -
Bacterial Toxin Fusion Proteins Elicit Mucosal Immunity against a Foot-and-Mouth Disease Virus Antigen When Administered Intranasally to Guinea Pigs
by: Sreerupa Challa, et al.
Published: (2011-01-01)